HGF and breast carcinoma: Hepatocyte growth factor (HGF) signaling via the receptor, c-MET, is related with the transformation of leiomyosarcoma cells, breast carcinoma cells, melanoma cells, and lung cancer cells in conjunction with SRC kinase which stimulate the expression of STAT3 (4–7).